Fluoxetine 20 MG
Sponsors
Hospices Civils de Lyon, Cardresearch, Hospital Regional 1o de Octubre, Tanta University, Wake Forest University Health Sciences
Conditions
Covid19DepressionDepressive DisorderEnuresisEnuresis, NocturnalEpilepsyHot FlashesIctal/Post-ictal Hypoxemia
Phase 2
Phase 3
Efficacy of Fluoxetine Against Seizure-induced Central Apneas
CompletedNCT02569970
Start: 2010-11-30End: 2015-01-31Updated: 2016-10-05
Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms
RecruitingNCT04727424
Start: 2021-01-19End: 2024-07-01Target: 7819Updated: 2024-05-08
Phase 4
Unknown Phase
Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome
CompletedNCT05346445
Start: 2021-01-20End: 2021-12-20Updated: 2022-07-26
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
NCT06185361
Start: 2022-12-01End: 2024-03-01Updated: 2023-12-29